MedPath

Comparing the Effect of Betamethasone and Ketorolac Injection on Treatment of De Quervain`s Tenosynovitis

Phase 3
Recruiting
Conditions
De Quervains tenosynovitis.
Radial styloid tenosynovitis [de Quervain]
M65.4
Registration Number
IRCT20220611055139N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

De Quervains Tenosynovitis Patients
Diabetes mellitus Type 2 Patients
Persons more than 18 yo ages

Exclusion Criteria

History of Allergic Reaction to Lidocaine ?Ketorolac (and other NSAIDs) ?Aspirin and Betamethasone
History of Corticosteroids Injection in past 3 months
History of surgery due to De Quervain`s Tenosynovitis in same wrist
Pregnant ?Breastfeeding period and Patient with Gestational Diabetes
Skin complications such as wounds, eczema or rash at the injection site
Active infection at the injection site
History of acute wrist trauma, history of wrist fracture, rheumatoid arthritis, uncontrolled diabetes
Patients with type 1 diabetes

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of pain described by the patient. Timepoint: first session, 6 week, 3 months ,6 months after injection. Method of measurement: Visual Analogue Scale Score.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath